Biohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Knowing when to adjust your financial plan can significantly impact your financial success. Learn key indicators for making timely adjustments.
23,637 articlesA patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Two software leaders battle for your 2026 portfolio: Duolingo and Zeta Global. This guide compares business models, g...
What’s going with stock? AMD is riding a data center and AI wave. This guide breaks down the drivers, risks, and real...
CoreWeave stock tumbling today underscores the volatility in AI infrastructure plays. This explainer breaks down what...
A hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
Investors eye dividend income to replace a $70,000 salary. This piece breaks down three yield-based paths and the cap...
As AI accelerates, a handful of chipmakers stand to benefit the most. This guide highlights four brilliant chip stock...
A new study links early retirement with faster cognitive decline, urging Gen X to stay in the workforce longer. Econo...
KBR has endured a tough year, with the stock fallen this past year by about 45%. A fresh stake worth $24 million from...
The space economy is expanding, yet investing in it without a plan can blow up portfolios. This guide explains why wa...
No stock goes straight up, and Walmart’s latest report is a perfect example. Strong e-commerce gains meet a cautious ...
Three under-the-radar high-yield ETFs are delivering higher income in a market where cash yields rise. This report br...